Launch — Access limited to 250 Members to ensure personalized follow-up quality.

Grey Hair: Is It Possible to Slow or Reverse the Process?

Single hair showing a pigmented-to-white transition against a dark background, studio lighting

For decades, hair greying was considered a biological inevitability, a one-way process. Pigment cells die, the hair turns white, end of story. This view was wrong.

In 2023, a team at NYU demonstrated that the stem cells responsible for pigmentation do not disappear. They become stuck in the wrong location within the hair follicle. It is a positioning problem, not a cell death problem. And this distinction changes everything, because a stuck cell can theoretically be remobilised. A dead cell cannot.

The mechanism finally understood: stem cells that stop migrating

Hair colour depends on a specific cell type: the melanocyte. Mature melanocytes produce melanin (the pigment that colours the hair) and transfer it to keratinocytes (the structural cells of the hair) during the growth phase. But mature melanocytes do not renew themselves. They are supplied by a reservoir of melanocyte stem cells (McSCs), housed in a region of the follicle called the bulge.

What the study by Qi Sun and Mayumi Ito revealed is that these McSCs possess a unique property among adult stem cells: they continuously shuttle between the bulge and the germinal matrix of the follicle (PubMed). At each hair cycle, they migrate to the germinal matrix, where they receive Wnt signals (a family of intercellular signalling proteins) that trigger their differentiation into functional melanocytes. Then they return to the bulge, dedifferentiate and become stem cells again. This back-and-forth movement is the engine of pigmentation.

The problem arises with age and repeated hair cycles. Progressively, an increasing number of McSCs remain trapped in the bulge. They no longer migrate to the germinal matrix. Without exposure to Wnt signals, they no longer differentiate. The follicle continues producing a hair, but without pigment.

~15% → 50%
Stuck McSCs with ageing

In mice, the proportion of follicles containing McSCs trapped in the bulge rises from about 15% in young animals to nearly 50% in aged ones.

Before this discovery, the dominant model was one of pure stem cell exhaustion. McSCs were thought to progressively die, irreversibly emptying the pool. The NYU study demonstrates a more nuanced reality: the cells are still there, but they have lost their motility. It is their shuttling ability, not their existence, that is compromised.

Stress: a documented accelerator, and partially reversible

The anecdote of Marie Antoinette whose hair allegedly turned white the night before her execution is probably apocryphal. But the link between stress and hair greying is solidly established.

In 2020, Ya-Chieh Hsu's team at Harvard identified the precise mechanism (PubMed). It is not cortisol that greying hair. Nor is it the immune system. It is the sympathetic nervous system. Under acute stress, sympathetic nerve endings in the hair follicle release norepinephrine directly onto McSCs. This burst forces the stem cells out of quiescence, into massive proliferation, then irreversible differentiation. The reservoir empties within a few cycles.

The result is spectacular in murine models: mice subjected to acute stress turn grey within weeks. Pharmacological blockade of beta-2 adrenergic receptors (the target of norepinephrine on McSCs) entirely prevents greying. Ablation of the adrenal glands (the source of cortisol) changes nothing. The evidence is clear: it is norepinephrine, not cortisol, that destroys the pigmentary reservoir.

But the story does not end there. In 2021, Martin Picard's team at Columbia provided an unexpected finding: greying can be reversible (PubMed). By analysing pigmentation along individual human hairs (hair records its chromatic history like tree rings), the researchers documented cases where white hairs had spontaneously regained their colour. And these repigmentation episodes correlated with periods of reduced stress reported by the subjects.

Proteomic analysis of the white segments revealed an upregulation of mitochondrial proteins and metabolic stress markers. Repigmentation was accompanied by normalisation of these profiles. Greying is therefore not always a point of no return. A reversibility threshold exists, as long as the McSC reservoir has not been entirely depleted.

Nutrition and oxidative stress: the biochemical terrain of greying

Alongside the discoveries about McSCs, another body of research has highlighted the central role of oxidative stress in pigment loss. In 2009, Karin Schallreuter's team published a landmark finding: white hair follicles accumulate hydrogen peroxide (H2O2) at millimolar concentrations, far above normal physiological levels (PubMed).

The reason: a near-total collapse of catalase, the enzyme that breaks down H2O2 into water and oxygen. Without catalase, hydrogen peroxide accumulates and oxidises tyrosinase, the key enzyme in melanin synthesis, rendering it inactive. The follicle bleaches from the inside out, chemically.

This mechanism is not isolated from the nutritional context. Catalase requires iron as a cofactor. Glutathione peroxidase (GPx), which handles H2O2 at lower concentrations, depends on selenium. Superoxide dismutase (SOD), the first line of defence against superoxide radicals, requires copper and zinc. A deficit in any of these micronutrients weakens the entire follicular antioxidant chain.

Clinical data confirm this connection. A prospective study in 2017 measured serum levels of vitamin B12, folate and biotin in patients with premature canities (greying before age 25). Results: B12 at 198 pg/mL in patients versus 343 pg/mL in controls, and folate at 6.22 ng/mL versus 8.49 ng/mL (PubMed). The differences are significant. B12 is essential for cell division in melanocyte precursors and for methionine metabolism, which feeds glutathione synthesis.

Copper is equally critical. It is a direct cofactor of tyrosinase. A case-control study showed significantly lower serum copper in prematurely greying subjects (90.7 versus 105.3 µg/dL) (PubMed). Iron, a cofactor of dopachrome tautomerase (DCT, another enzyme in the melanin pathway), shows the same pattern.

In 2020, a study measuring systemic oxidative stress markers showed that reduced glutathione was nearly halved in patients with premature canities (177.8 versus 319.0 µg/mL), with a progressive elevation of malondialdehyde (a lipid peroxidation marker) correlating with greying severity (PubMed).

The most striking case of nutritional reversibility remains that of an 11-year-old child whose white hair fully repigmented after 5 months of ferrous sulphate supplementation, correcting severe iron deficiency anaemia (ferritin rising from 2.6 to 15.1 ng/mL) (PubMed). Similar cases of repigmentation following B12 deficit correction (particularly in the context of pernicious anaemia) are documented in the literature.

Therapeutic avenues: what research is exploring

No validated treatment currently exists to reverse hair greying. But several avenues are sufficiently advanced to warrant attention.

Topical rapamycin. In 2023, a study on cultured human hair follicles showed that rapamycin (an mTORC1 inhibitor, the cell signalling pathway linked to growth) reactivates melanin production in grey follicles still containing residual melanocytes (PubMed). The mechanism: mTORC1 inhibition increases intrafollicular production of alpha-MSH (the hormone that stimulates melanocytes via the MC1R receptor). Grey follicles exhibit abnormally elevated mTORC1 activity. Correcting it partially restores pigmentation.

Natural beta-blockers. If norepinephrine is the culprit identified by the Harvard study, blocking its receptor (the beta-2 adrenergic receptor) should protect McSCs. This is precisely what two studies on plant-derived compounds demonstrated: rhynchophylline (from Uncaria, "cat's claw") and isoliensinine (from sacred lotus, Nelumbo nucifera). Applied transdermally in stressed mice, these molecules reduced greying comparably to propranolol (a synthetic beta-blocker) (PubMed).

Biomimetic peptides. Palmitoyl tetrapeptide-20 (a synthetic alpha-MSH analogue) activates the MC1R receptor, stimulates tyrosinase and reduces intracellular H2O2 by 30% through catalase activation. In vitro data are encouraging. A clinical trial on 14 patients, however, did not show convincing efficacy, tempering initial optimism (PubMed).

Wnt pathway modulators. Since McSC trapping in the bulge results from a lack of exposure to Wnt signals, reactivating this pathway in the follicle is a logical therapeutic target. Sterubin (a flavonoid from Eriodictyon angustifolium) activates the Wnt/MITF/tyrosinase cascade and has shown grey hair reduction in small human studies (PubMed). A phase 1/2 clinical trial (CS-001, Applied Biology) is currently recruiting 240 patients to evaluate a molecule targeting melanin storage and transfer in the follicle.

A landmark review published in the Journal of Investigative Dermatology in 2024 synthesises current knowledge (PubMed). The current consensus: greying results from an individually variable mix of cumulative oxidative damage, excessive mTORC1 activity, melanocyte senescence, Wnt signalling defects and insufficient production of pigmentogenic factors (HGF, KIT ligand, alpha-MSH). The most promising intervention window targets early anagen (the beginning of the growth cycle), when McSCs are most receptive to differentiation signals.

Hair greying is no longer a black box. The mechanisms are identified: stuck stem cells, norepinephrine, oxidative stress, enzymatic and nutritional deficits. Therapeutic targets exist. What is missing are large-scale human clinical trials, and the patience needed to distinguish molecules that truly work from those that do not survive the leap from mouse to man. The science of grey hair has just undergone a paradigm shift. Applications will follow.

Frequently asked questions


References

  1. Sun Q, Lee W, Hu H, et al. Dedifferentiation maintains melanocyte stem cells in a dynamic niche. Nature. 2023;616(7958):774-782 (PubMed).
  2. Zhang B, Ma S, Rachmin I, et al. Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells. Nature. 2020;577(7792):676-681 (PubMed).
  3. Rosenberg AM, Rausser S, Ren J, et al. Quantitative mapping of human hair greying and reversal in relation to life stress. eLife. 2021;10:e67437 (PubMed).
  4. Wood JM, Decker H, Hartmann H, et al. Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J. 2009;23(7):2065-2075 (PubMed).
  5. Daulatabad D, Singal A, Grover C, Chhillar N. Prospective analytical controlled study evaluating serum biotin, vitamin B12, and folic acid in patients with premature canities. Int J Trichology. 2017;9(1):19-24 (PubMed).
  6. Fatemi Naieni F, Ebrahimi B, Vakilian HR, Shahmoradi Z. Serum iron, zinc, and copper concentration in premature graying of hair. Biol Trace Elem Res. 2012;146(1):30-34 (PubMed).
  7. Saxena S, Gautam RK, Gupta A, Chitkara A. Evaluation of systemic oxidative stress in patients with premature canities and correlation of severity of hair graying with the degree of redox imbalance. Int J Trichology. 2020;12(1):22-30 (PubMed).
  8. Choi JW, Lew BL, Sim WY. A case of premature hair graying treated with ferrous sulfate. Ann Dermatol. 2016;28(6):757-759 (PubMed).
  9. Suzuki T, Chéret J, Scala FC, et al. mTORC1 activity negatively regulates human hair follicle growth and pigmentation. EMBO Rep. 2023;24(7):e56574 (PubMed).
  10. Li X, Shi R, Yan L, et al. Natural product rhynchophylline prevents stress-induced hair graying by preserving melanocyte stem cells via the β2 adrenergic pathway suppression. Nat Prod Bioprospect. 2023;13(6):54 (PubMed).
  11. Almeida Scalvino S, Chapelle A, Hajem N, et al. Efficacy of an agonist of α-MSH, the palmitoyl tetrapeptide-20, in hair pigmentation. Int J Cosmet Sci. 2018;40(5):516-524 (PubMed).
  12. Taguchi N, Hata T, Kamiya E, et al. Reduction in human hair graying by sterubin, an active flavonoid of Eriodictyon angustifolium. J Dermatol Sci. 2018;92(3):283-289 (PubMed).
  13. Paus R, Sevilla A, Grichnik JM. Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers. J Invest Dermatol. 2024;144(3):474-491 (PubMed).